Skip to Content

IN150 > (Ibandronate Sodium 150 mg (base))

Pill with imprint IN150 > is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc..

Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for IN150 >

Ibandronate sodium 150 mg (base) IN150 >
Ibandronate sodium 150 mg (base) IN150 >
Ibandronate sodium 150 mg (base) IN150 >

Ibandronate Sodium

Imprint
IN150 >
Strength
150 mg (base)
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-3770 Watson Pharmaceuticals, Inc.
42291-0336 AvKare, Inc.

Get help with Imprint Code FAQs.

Related Images for "IN150 >"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.